Drug and Alcohol Testing 25+

The procurement process for the "Drug and Alcohol Testing 25+" contract has been completed, with Nuclear Restoration Services acting as the buying organisation. This tender, focusing on the provision of drug and alcohol testing services, falls under the industry category of drug detection and laboratory services. The procurement was conducted via a selective method, specifically a call-off from a framework agreement.

The process reached the award stage, with the contract awarded to Abbott Toxicology Limited on 29th September 2025. The contract period runs from 1st December 2025 to 30th November 2029 and is valued at £243,000. The geographical scope includes the United Kingdom and various international locations, offering extensive service coverage.

This tender presents significant growth opportunities for businesses experienced in drug detection and laboratory services, especially for those with capabilities in delivering comprehensive testing solutions across multiple regions. Companies specialised in providing testing apparatus and health services could find this contract advantageous. Small and medium-sized enterprises (SMEs) are deemed suitable for this opportunity, suggesting a favourable landscape for businesses looking to expand within the public sector market.

The substantial contract value and extended duration further enhance its attractiveness for companies seeking long-term engagements.